Abstract: The present invention pertains to a device (1) for the treatment of, treatment of complications arising from, and/or preventing respiratory disorders caused by bacterial, viral, protozoal, fungal and/or microbial infections, preferably for the treatment of complications arising from cystic fibrosis (CF), including a positive airway pressure device (2) for providing a breathing gas under a positive pressure to a patient interface (20), a source of nitric oxide (3) for providing gaseous nitric oxide, a gas injector (4) for injecting nitric oxide provided by the source of nitric oxide (3) into the breathing gas provided by the positive airway pressure device (2) under pressure, a flow rate sensor (5) for sensing the flow rate of the breathing gas provided to the patient interface (20) under positive airway pressure, and a controller (6) programmed for controlling the gas injector (4) for injecting the nitric oxide into the breathing gas provided by the positive airway pressure device (2) when a flow rate detecte

Abstract: The present invention pertains to a device (1) for the treatment of respiratory disorders or complications thereof in a mammal with a gaseous mixture for use as an inhalable medicament, comprising a patient interface (3), a source (23) of air, a source (21) of gaseous nitric oxide, a source (22) of gaseous oxygen, an application device (4) for providing a gaseous mixture to a patient interface, at least one gas injector (5) for injecting nitric oxide provided by the source of gaseous nitric oxide into the gaseous mixture provided by the application device, at least one gas injector (6) for injecting oxygen provided by the source of gaseous oxygen into the gaseous mixture provided by the application device, and a controller (8) programmed for controlling the at least one gas injector and the application device, wherein the source of gaseous nitric oxide comprises an arrangement (210) for onsite production of nitric oxide, and the source of gaseous oxygen comprises an arrangement (220) for onsite enrichment of

Abstract: An apparatus for the treatment of infections associated with respiratory disorders in a mammal with a mixture for use as an inhalable medicament. The apparatus includes a patient interface, at least one source of helium for providing gaseous helium, at least one source of oxygen for providing gaseous oxygen, an application device for providing a mixture to the patient interface, at least one source of nitric oxide for providing gaseous nitric oxide, a gas injector for injecting the nitric oxide into the mixture, an injector for injecting a means for inhibiting growth of pulmonary pathogens, a controller programmed for controlling the gas injector, the application device and the injector.

Abstract: The present invention pertains to a device (1) for ventilating a patient, including an invasive mechanical ventilator (2) for periodically providing a breathing gas to an invasive patient interface (20), wherein a gas injector (4) for injecting nitric oxide supplied by a source of nitric oxide (3) into the breathing gas supplied by the invasive mechanical ventilator (2) is provided.

Abstract: The present invention pertains to a device (1) for the treatment of, treatment of complications arising from, and/or preventing respiratory disorders caused by bacterial, viral, protozoal, fungal and/or microbial infections, preferably for the treatment of complications arising from cystic fibrosis (CF), including a positive airway pressure device (2) for providing a breathing gas under a positive pressure to a patient interface (20), a source of nitric oxide (3) for providing gaseous nitric oxide, a gas injector (4) for injecting nitric oxide provided by the source of nitric oxide (3) into the breathing gas provided by the positive airway pressure device (2) under pressure, a flow rate sensor (5) for sensing the flow rate of the breathing gas provided to the patient interface (20) under positive airway pressure, and a controller (6) programmed for controlling the gas injector (4) for injecting the nitric oxide into the breathing gas provided by the positive airway pressure device (2) when a flow rate detecte

Abstract: A method of automating the process of creating a remote mirror of a relational database management system (RDBMS) includes discovering storage configuration and database layout at a primary database, relaying this information to a backup storage subsystem, monitoring that database and storage systems for changes and conveying storage and/or database changes to the backup storage subsystem. A self-configuring backup mirroring system for dynamic relational configuration includes a source system monitoring one or more storage servers and a computer system running a RDBMS. A backup system provides a disaster recovery environment for the source system wherein backup storage components duplicate the source storage components. The backup system may be used to reconstruct the source storage system if necessary. Finally, software agents run at both the source and backup systems.